PortfoliosLab logo
OGN vs. OHI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between OGN and OHI is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

OGN vs. OHI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Organon & Co. (OGN) and Omega Healthcare Investors, Inc. (OHI). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

OGN:

-1.08

OHI:

1.41

Sortino Ratio

OGN:

-1.59

OHI:

1.92

Omega Ratio

OGN:

0.78

OHI:

1.24

Calmar Ratio

OGN:

-0.73

OHI:

2.12

Martin Ratio

OGN:

-1.93

OHI:

4.39

Ulcer Index

OGN:

28.66%

OHI:

6.54%

Daily Std Dev

OGN:

51.56%

OHI:

21.06%

Max Drawdown

OGN:

-75.77%

OHI:

-94.85%

Current Drawdown

OGN:

-72.75%

OHI:

-8.24%

Fundamentals

Market Cap

OGN:

$2.28B

OHI:

$10.82B

EPS

OGN:

$3.14

OHI:

$1.61

PE Ratio

OGN:

2.79

OHI:

22.58

PS Ratio

OGN:

0.36

OHI:

9.97

PB Ratio

OGN:

4.21

OHI:

2.22

Total Revenue (TTM)

OGN:

$6.29B

OHI:

$1.08B

Gross Profit (TTM)

OGN:

$3.60B

OHI:

$1.07B

EBITDA (TTM)

OGN:

$1.50B

OHI:

$989.65M

Returns By Period

In the year-to-date period, OGN achieves a -38.15% return, which is significantly lower than OHI's 1.43% return.


OGN

YTD

-38.15%

1M

-16.26%

6M

-38.61%

1Y

-55.75%

5Y*

N/A

10Y*

N/A

OHI

YTD

1.43%

1M

-1.53%

6M

-4.09%

1Y

29.47%

5Y*

16.39%

10Y*

8.52%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

OGN vs. OHI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OGN
The Risk-Adjusted Performance Rank of OGN is 44
Overall Rank
The Sharpe Ratio Rank of OGN is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of OGN is 55
Sortino Ratio Rank
The Omega Ratio Rank of OGN is 44
Omega Ratio Rank
The Calmar Ratio Rank of OGN is 77
Calmar Ratio Rank
The Martin Ratio Rank of OGN is 11
Martin Ratio Rank

OHI
The Risk-Adjusted Performance Rank of OHI is 8787
Overall Rank
The Sharpe Ratio Rank of OHI is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of OHI is 8484
Sortino Ratio Rank
The Omega Ratio Rank of OHI is 8282
Omega Ratio Rank
The Calmar Ratio Rank of OHI is 9494
Calmar Ratio Rank
The Martin Ratio Rank of OHI is 8484
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

OGN vs. OHI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Organon & Co. (OGN) and Omega Healthcare Investors, Inc. (OHI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current OGN Sharpe Ratio is -1.08, which is lower than the OHI Sharpe Ratio of 1.41. The chart below compares the historical Sharpe Ratios of OGN and OHI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

OGN vs. OHI - Dividend Comparison

OGN's dividend yield for the trailing twelve months is around 9.51%, more than OHI's 7.24% yield.


TTM20242023202220212020201920182017201620152014
OGN
Organon & Co.
9.51%7.51%7.77%4.01%1.84%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
OHI
Omega Healthcare Investors, Inc.
7.24%7.08%8.74%9.59%9.06%7.38%6.26%7.51%9.22%7.55%6.23%5.17%

Drawdowns

OGN vs. OHI - Drawdown Comparison

The maximum OGN drawdown since its inception was -75.77%, smaller than the maximum OHI drawdown of -94.85%. Use the drawdown chart below to compare losses from any high point for OGN and OHI. For additional features, visit the drawdowns tool.


Loading data...

Volatility

OGN vs. OHI - Volatility Comparison

Organon & Co. (OGN) has a higher volatility of 37.83% compared to Omega Healthcare Investors, Inc. (OHI) at 6.65%. This indicates that OGN's price experiences larger fluctuations and is considered to be riskier than OHI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

OGN vs. OHI - Financials Comparison

This section allows you to compare key financial metrics between Organon & Co. and Omega Healthcare Investors, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B2.50B3.00B3.50B20212022202320242025
1.51B
276.79M
(OGN) Total Revenue
(OHI) Total Revenue
Values in USD except per share items

OGN vs. OHI - Profitability Comparison

The chart below illustrates the profitability comparison between Organon & Co. and Omega Healthcare Investors, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%100.0%20212022202320242025
55.6%
98.8%
(OGN) Gross Margin
(OHI) Gross Margin
OGN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Organon & Co. reported a gross profit of 841.00M and revenue of 1.51B. Therefore, the gross margin over that period was 55.6%.

OHI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Omega Healthcare Investors, Inc. reported a gross profit of 273.47M and revenue of 276.79M. Therefore, the gross margin over that period was 98.8%.

OGN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Organon & Co. reported an operating income of 325.00M and revenue of 1.51B, resulting in an operating margin of 21.5%.

OHI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Omega Healthcare Investors, Inc. reported an operating income of 156.45M and revenue of 276.79M, resulting in an operating margin of 56.5%.

OGN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Organon & Co. reported a net income of 87.00M and revenue of 1.51B, resulting in a net margin of 5.8%.

OHI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Omega Healthcare Investors, Inc. reported a net income of 109.03M and revenue of 276.79M, resulting in a net margin of 39.4%.